You are here: Industry Insights > china

News List

Artemisinin has become the world’s most powerful weapon against malaria en-cphi.cn
May 12, 2017
Inherence but not obstinately following tradition; innovation but not departing from the original stand.
Shineco, Inc. Retains Ascent Investor Relations LLC en-cphi.cn
May 12, 2017
Shineco, Inc. a producer and distributor of Chinese herbal medicines, organic agricultural produce, specialized textiles.
Echosens Wins in Germany a Major Trial for IP Infringement Against Wuxi Hisky Medical en-cphi.cn
May 11, 2017
For more than fifteen years, Echosens has developed and sold worldwide its FibroScan® devices that utilise its unique VCTE™ technology, which is protected worldwide by a portfolio of several patents.
Crown Bioscience Enters Antibody Collaboration contractpharma
May 10, 2017
Crown Bioscience will collaborate to develop a cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) antibody with Jiangsu Qyun Bio-Pharmaceutical.
Sonova Opens Global Hearing Institute in China en-cphi.cn
May 09, 2017
Sonova officially opened its first Audiology Training Center in Suzhou, Jiangsu Province, China. The Sonova Global Hearing Institute is a state of the art training center for current and future hearing care professionals.
Withdraw ‘TRIPS-plus’ proposals: MSF to Japan, S Korea financialexpress
May 08, 2017
Response targets the 18th round of the RCEP trade talks, to be held in Manila this week
Myth of the Mouse Nerve Growth Factor in China: The Market Size Expanded by Nearly 8 Times in 5 Year en-cphi.cn
May 05, 2017
As the regulatory factor for cell growth first discovered, the nerve growth factor (NGF) features dual biological functions of nourishing neurons and promoting neurite growth...
39 Pharmaceutical Products to be Checked on Site, Foreign Pharmaceutical Enterprises Having Defects en-cphi.cn
May 05, 2017
Center for Food and Drug Inspection of CFDA issued the Announcement on On-site Checking Plan for Drug Clinical Trial Data No. 11 on April 28.
Sorrento Completes GMP Mfg. Plant in Suzhou contractpharma
May 05, 2017
Will support Antibody-Drug Conjugate (ADC) pipeline and service business
IMPACT Received IMP4297 Chinese IND Approval en-cphi.cn
May 04, 2017
IMPACT Therapeutics, Inc. (IMPACT) announced that CFDA granted approval to its IND application of IMP4297, a potential best-in-class PARP inhibitor, in January 2017.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 38 39 Next page